3.4 C
Glasgow
Tuesday, December 16, 2025
spot_img

More News

Vivacta Bio shows promising results for in vivo CAR-T therapy in non-Hodgkin’s lymphoma

Jim Cornall -
Vivacta Bio, a spin-off company of Grit Biotherapeutics advancing in vivo CAR-T therapies for oncology and autoimmune diseases, has...

OTR Therapeutics raises $100m for global transformative therapies

Jim Cornall -
OTR Therapeutics has emerged from stealth and announced the successful completion of a $100m Series A financing. The round was...

Base to Base biotech podcast 39: Gene therapy for eye problems, GAIA, and separation science

Jim Cornall -
This week, we have conversations with Jakob Andersson, vice president of engineering at Anaphora and founder and chairman of...

Endpoints not met, but data provides insights to Alzheimer’s pathobiology

Jim Cornall -
Novo Nordisk has presented new topline results from its Evoke and Evoke+ phase 3 trials of semaglutide, an oral...

CRS programme to feature Poolbeg Pharma trial

Jim Cornall -
Poolbeg Pharma’s POLB 001 TOPICAL trial is to feature in a cancer immunotherapy-induced cytokine release syndrome (CRS) research programme. Poolbeg...

ChemLex raises $45m and launches lab for drug discovery in Singapore

Jim Cornall -
ChemLex has announced the establishment of its global headquarters and self-driving laboratory in Singapore, alongside the close of a...

Potent and selective antitumour activity in acute myeloid leukaemia study

Jim Cornall -
Orum Therapeutics, a public biotechnology company working on degrader-antibody conjugates (DACs), has presented preclinical data for ORM-1153 at the...

Positive results from male and female infertility monoclonal antibody trial

Jim Cornall -
French infertility treatment biotech company Igyxos Biotherapeutics has announced the successful completion of its phase 1 clinical trial evaluation...

Positive results from ALS study

Jim Cornall -
AL-S Pharma has presented phase 2 clinical study results on AP-101 to treat amyotrophic lateral sclerosis (ALS) at the...

EspeRare receives Gates Foundation grant to advance preeclampsia novel therapy

Jim Cornall -
EspeRare, a Geneva-based nonprofit biotech, has been awarded a Grand Challenges grant from the Gates Foundation to strengthen its...

CRO Avetra launched

Jim Cornall -
Contract research organization (CRO) Avetra has officially launched with the aim of introducing a site-centric operating model to realign...

7,920 acre next-gen industry facility IBTEC launched in Malaysia

Jim Cornall -
JLand Group (JLG), the real estate and infrastructure arm of Johor Corporation (JCorp) in Malaysia, has launched Ibrahim Technopolis...

Oncoinvent publishes phase 1 ovarian cancer results

Jim Cornall -
Oncoinvent, a clinical stage, radiopharmaceutical company developing treatments for solid cancers, has announced the publication of 12-month data from...

Lower doses of immunotherapy for skin cancer give better results

Jim Cornall -
According to a new study, lower doses of approved immunotherapy for malignant melanoma can give better results against tumours,...

New RNA class discovered

Jim Cornall -
Inside cells, RNAs and proteins form tiny, liquid-like droplets called biomolecular condensates. These droplets are essential for organising cellular...

Base to Base biotech podcast 38: Obesity, life sciences in the Netherlands, and killing cancer cells

Jim Cornall -
This week, we have conversations with Sjanna Bosma, international relations officer at Health Holland; Mark Bagnall, CEO of Phenomix;...

IonQ and CCRM to collaborate on advanced therapeutics

Jim Cornall -
Quantum company IonQ has announced an investment partnership with the Centre for Commercialization of Regenerative Medicine (CCRM) to accelerate...

Researchers discover latent antimicrobial resistance across the world

Jim Cornall -
A group of researchers has analysed 1,240 wastewater samples from 351 cities in 111 different countries and found that...

Early detection of cancer in Taiwan

Jim Cornall -
Precision medicine is entering a new era, driven by breakthroughs in genetic technology and artificial intelligence (AI). Multi-cancer early...

Protego Biopharma raises $130m for AL amyloidosis programme

Jim Cornall -
Protego Biopharma, Inc., a clinical-stage biotechnology company dedicated to pioneering first-in-class small molecule therapeutics that reprogramme protein folding to...

Belgian company looks to Uzbekistan to expand biotech footprint

Jim Cornall -
Deputy Minister of Investment, Industry and Trade of the Republic of Uzbekistan, Akram Aliyev, held a meeting with the...

Deeptech Digest is your guide to what's new in at the cutting edge of science technology. A bit of artificial intelligence, some biotech, and all the news and latests developments in the field. If it's deeptech, it's in Deeptech Digest!

Contact us: jim@deeptechdigest.com

© 2023 Ayr Coastal Media